{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T06:22:15Z","timestamp":1792995735770,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.hrthm.2026.03.003","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T08:03:37Z","timestamp":1772870617000},"page":"1585-1591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Activated clotting time platforms matter: Evidence gaps and real-world variability in anticoagulation targets during left atrial ablation"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7972-5199","authenticated-orcid":false,"given":"Boldizsar","family":"Kovacs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valon","family":"Spahiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina L.","family":"Rohrbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Sch\u00f6ppenthau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kurath-Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Stojkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Simovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kueffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Vandenberk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Linz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Vernooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Roten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Dinshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Reichlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2026.03.003_bib1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3174\/ajnr.A2621","article-title":"Point-of-care testing for anticoagulation monitoring in neuroendovascular procedures","volume":"33","author":"Hussein","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.hrthm.2026.03.003_bib2","doi-asserted-by":"crossref","first-page":"euae043","DOI":"10.1093\/europace\/euae043","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"26","author":"Tzeis","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2026.03.003_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/jce.12975","article-title":"Clinical impact of heparin kinetics during catheter ablation of atrial fibrillation: meta-analysis and meta-regression","volume":"27","author":"Briceno","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.03.003_bib4","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1016\/j.hrthm.2024.12.023","article-title":"ACT targets during atrial fibrillation ablation","volume":"22","author":"Boyle","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.03.003_bib5","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.jacc.2004.01.031","article-title":"Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography","volume":"43","author":"Ren","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.03.003_bib6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1046\/j.1540-8167.2005.40465.x","article-title":"Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast","volume":"16","author":"Ren","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.03.003_bib7","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/615087","article-title":"Early heparin administration reduces risk for left atrial thrombus formation during atrial fibrillation ablation procedures","volume":"2011","author":"Asbach","year":"2011","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.hrthm.2026.03.003_bib8","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1046\/j.1460-9592.2003.t01-1-00208.x","article-title":"Radiofrequency catheter ablation: different cooled and noncooled electrode systems induce specific lesion geometries and adverse effects profiles","volume":"26","author":"Dorwarth","year":"2003","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.03.003_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10840-008-9270-x","article-title":"Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation","volume":"22","author":"Bruce","year":"2008","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.03.003_bib10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/europace\/eus027","article-title":"2012 HRS\/EHRA\/ECAS Expert Consensus Statement on Catheter and Surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design","volume":"14","author":"Calkins","year":"2012","journal-title":"Europace"},{"issue":"suppl 1","key":"10.1016\/j.hrthm.2026.03.003_bib11","doi-asserted-by":"crossref","first-page":"i64","DOI":"10.1093\/europace\/euy015.180","article-title":"Comparison of three methods of activated clotting time (ACT) measurement during catheter ablation for atrial fibrillation","volume":"20","author":"Bulkova","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2026.03.003_bib12","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.hlc.2020.09.204","article-title":"197 activated clotting time assessment during left heart catheter ablation: differences between i-STAT and Hemochron","volume":"29","author":"Puchalski","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hrthm.2026.03.003_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/10760296251332938","article-title":"Activated clotting time requires adaptation across altered measurement devices: determination of appropriate range during atrial fibrillation ablation","volume":"31","author":"Sakanoue","year":"2025","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.hrthm.2026.03.003_bib14","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.hroo.2025.03.014","article-title":"Activated clotting time for anticoagulation management during catheter ablation of left atrial arrhythmias: comparison of point-of-care devices in clinical routine","volume":"6","author":"F\u00fclkell","year":"2025","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.hrthm.2026.03.003_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00000542-200307000-00012","article-title":"Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test","volume":"99","author":"Paniccia","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.hrthm.2026.03.003_bib16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12871-019-0846-z","article-title":"Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability","volume":"19","author":"Dirkmann","year":"2019","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.hrthm.2026.03.003_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1051\/ject\/1987193265","article-title":"Activated clotting time (ACT): the reproducibility of three techniques","volume":"19","author":"Sillick","year":"1987","journal-title":"J Extra-Corpor Technol"},{"key":"10.1016\/j.hrthm.2026.03.003_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1051\/ject\/199022S027","article-title":"A clinical evaluation of the correlation and Reprodicibility of three automated devices for measurement of activated clotting times","volume":"22","author":"Dumond","year":"1990","journal-title":"J Extra-Corpor Technol"},{"key":"10.1016\/j.hrthm.2026.03.003_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1309\/AJCPSF8ASGONNQM6","article-title":"Clinical evaluation of the i-STAT kaolin activated clotting time (ACT) test in different clinical settings in a large academic urban medical center: comparison with the Medtronic ACT Plus","volume":"135","author":"Lewandrowski","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.hrthm.2026.03.003_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1160\/TH08-08-0528","article-title":"Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation","volume":"101","author":"Chia","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2026.03.003_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/labmed\/lmz014","article-title":"Intraoperative monitoring of heparin: comparison of activated coagulation time and whole blood heparin measurements by different point-of-care devices with heparin concentration by laboratory-performed plasma anti-Xa assay","volume":"50","author":"Thompson","year":"2019","journal-title":"Lab Med"},{"key":"10.1016\/j.hrthm.2026.03.003_bib22","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.hrthm.2014.03.013","article-title":"Atrial fibrillation ablation using open-irrigated tip radiofrequency: experience with intraprocedural activated clotting times \u2264210 seconds","volume":"11","author":"Winkle","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.03.003_bib23","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/s41591-024-03114-3","article-title":"Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study","volume":"30","author":"Ekanem","year":"2024","journal-title":"Nat Med"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126002171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126002171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:44:24Z","timestamp":1782722664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527126002171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1547527126002171"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.03.003","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activated clotting time platforms matter: Evidence gaps and real-world variability in anticoagulation targets during left atrial ablation","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}